Active Ingredient(s):Adalimumab-adbm FDA Approved: * August 25, 2017 Pharm Company: *BOEHRINGER INGELHEIM Category:Immunosuppressive
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. It is administered by injection under the skin.
Common side effects include upper respiratory tract infections, pain at the site o...
* May have multiple approval dates, manufacturers, or labelers.